Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type

Clinical and Experimental Immunology

Volumn 151, Issue 2, 2008, Pages 306-316

  Schoenbein, C ^a,b   Docke, W D ^b   Wolk, K ^a   Belbe, G ^a   Hoflich, C ^a   Jung, M ^a   Grutz, G ^a   Sterry, W ^a   Volk, H D ^a   Asadullah, K ^b   Sabat, R ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b TRG Inflammation/Immunology   (Germany)

Author keywords

Cell differentiation; Cytokines; Human; Monocytes macrophages

Indexed keywords

CD4 ANTIGEN; CD86 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CD4+ T LYMPHOCYTE; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOREGULATION; IN VITRO STUDY; INTENSIVE CARE; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ANTIGEN-PRESENTING CELLS; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION REGULATION; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; ISOANTIGENS; LYMPHOCYTE ACTIVATION; MONOCYTES; PSORIASIS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 37849011846     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03554.x     Document Type: Article

References (34)

1. Fiorentino DF, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989 170 : 2081 95.
2. de Waal Malefyt R, Moore KW, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001 19 : 683 765.
3. Kunz S, Wolk K, Witte E et al. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol 2006 15 : 991 1004.
4. de Waal Malefyt R, Spits H, Roncarolo MG et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991 174 : 915 24.
5. Willems F, Delville JP, Gerard C et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 1994 24 : 1007 9.
6. Fiorentino DF, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991 147 : 3815 22.
7. de Waal Malefyt R, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991 174 : 1209 20.
8. de Waal Malefyt R, te Velde AA, Huijbens RJ, de Vries JE, Figdor CG. IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10. J Immunol 1992 149 : 4048 52.
9. Calzada-Wack JC, Ziegler-Heitbrock HW. Interleukin-10 drives human monocytes to CD16 positive macrophages. J Inflamm 1996 46 : 78 85.
10. Lingnau M, Hoflich C, Volk HD, Sabat R, Docke WD. Interleukin-10 enhances the CD14-dependent phagocytosis of bacteria and apoptotic cells by human monocytes. Hum Immunol 2007 68 : 730 8.
11. Gotlieb WH, Watson JM, Velu TJ, Berek JS, Martinez-Maza O. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine 1992 4 : 385 90.
12. Asadullah K, Haeussler A, Sterry W, Volk HD. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. J Invest Dermatol 1996 107 : 833 7.
13. Fortis C, Gianotti L, Galli L et al. Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett 1996 104 : 1 5.
14. Ameglio F, Solmone M, Bonifati C et al. Serum IL-10 levels in HIV-positive subjects: correlation with CDC stages. J Biol Regul Homeost Agents 1994 8 : 48 52.
15. Herbst H, Samol J, Araujo I et al. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease. Blood 1996 87 : 2918 29.
16. Berney T, Gasche Y, Robert J et al. Serum profiles of interleukin-6, interleukin-8, and interleukin-10 in patients with severe and mild acute pancreatitis. Pancreas 1999 18 : 371 7.
17. Woiciechowsky C, Asadullah K, Nestler D et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998 4 : 808 13.
18. Heper Y, Akalin EH, Mistik R et al. Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 2006 25 : 481 91.
19. Gallina G, Dolcetti L, Serafini P et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006 116 : 2777 90.
20. Muehlstedt SG, Lyte M, Rodriguez JL. Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 2002 17 : 443 50.
21. Wolk K, von Baehr V, Volk HD, Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000 96 : 218 23.
22. Wolk K, Grutz G, Witte K, Volk HD, Sabat R. The expression of legumain, an asparaginyl endopeptidase that controls antigen processing, is reduced in endotoxin-tolerant monocytes. Genes Immun 2005 6 : 452 6.
23. Wolk K, Hoflich C, Zuckermann-Becker H, Docke WD, Volk HD, Sabat R. Reduced monocyte CD86 expression in postinflammatory immunodeficiency. Crit Care Med 2007 35 : 458 67.
24. Asadullah K, Hanneken S, Rohrbach C et al. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings. J Invest Dermatol 2001 116 : 721 7.
25. Wolk K, Witte E, Reineke U et al. Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 2005 6 : 8 18.
26. Wolk K, Witte E, Wallace E et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006 36 : 1309 23.
27. Johnson JG, Jenkins MK. The role of anergy in peripheral T cell unresponsiveness. Life Sci 1994 55 : 1767 80.
28. Van Ginderachter JA, Meerschaut S, Liu Y et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 2006 108 : 525 35.
29. Katakura T, Miyazaki M, Kobayashi M, Herndon DN, Suzuki F. CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J Immunol 2004 172 : 1407 13.
30. Schebesch C, Kodelja V, Muller C et al. Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 1997 92 : 478 86.
31. Edwards JP, Zhang X, Frauwirth KA, Mosser DM. Biochemical and functional characterization of three activated macrophage populations. J Leukoc Biol 2006 80 : 1298 307.
32. MacDonald KP, Rowe V, Clouston AD et al. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. J Immunol 2005 174 : 1841 50.
33. Rutella S, Bonanno G, Pierelli L et al. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur J Immunol 2004 34 : 1291 302.
34. Bellone G, Carbone A, Smirne C et al. Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J Immunol 2006 177 : 3448 60.